Latest News and Press Releases

THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION Acacia Pharma Group plc  Change of EU home Member State Cambridge, UK and Indianapolis, US – 18 February 2021, 09:00 CET: Acacia Pharma Group plc...

Acacia Pharma Group plc  Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Cambridge, UK and Indianapolis, US – 12 February 2021: Acacia Pharma Group plc (“Acacia Pharma”,...

Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Cambridge, UK and Indianapolis, US – 4 February 2021: Acacia Pharma Group plc (“Acacia Pharma”, the...

Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less Approximately 40 million procedures take...

 Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference Cambridge, UK and Indianapolis, US – 21 January 2021: Acacia Pharma Group plc (“Acacia Pharma” or the...

Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Cambridge, UK and Indianapolis, US – 20 January 2021: Acacia Pharma Group plc (“Acacia Pharma”, the...

 Acacia Pharma wins BEL Small Company of the Year for the second consecutive year This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No...

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...